Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
about
Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancerEpigenetic regulation of insulin-like growth factor axis in hepatocellular carcinomaHepatocellular adenoma: An update.Targeting the insulin-like growth factor pathway in hepatocellular carcinomaMolecular pathogenesis of hepatic adenomas and its implications for surgical managementEpithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?Genomic imprinting: implications for human disease.A patient with Simpson-Golabi-Behmel syndrome and hepatocellular carcinoma.Imprinted genes as potential genetic and epigenetic toxicologic targetsThe IGF axis and hepatocarcinogenesis.The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets.Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27Keys to the hidden treasures of the mannose 6-phosphate/insulin-like growth factor 2 receptor.Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas.Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomasLoss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis.Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma.PHF10 is required for cell proliferation in normal and SV40-immortalized human fibroblast cellsMannose 6-phosphate receptor targeting and its applications in human diseases.Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma.Differential roles of insulin-like growth factor receptor- and insulin receptor-mediated signaling in the phenotypes of hepatocellular carcinoma cells.IGF-1R as an anti-cancer target--trials and tribulationsA phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma.Type I insulin-like growth factor receptor signaling in hematological malignancies.Molecular targeted therapy for hepatocellular carcinoma: current and future.WWOX, large common fragile site genes, and cancer.M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residuesLiver stem cells and molecular signaling pathways in hepatocellular carcinoma.Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3.
P2860
Q24337644-925BC08F-6367-4AB9-A9BB-5B24FB828D83Q26766068-2AF3B6E6-306A-4E06-9EF0-6B531F1981DEQ26777656-4C58762E-BEF8-41AB-BBB9-5DFC92D4C26BQ27006846-0C64E458-2C84-4A64-B879-DBFD2D4DCF4FQ27027370-29514F4F-9545-410E-B48A-5CC05CB29DEBQ28087055-235079B9-AD0E-4383-A0AA-C0533CEA0274Q33541538-D3D69379-871A-4DFA-9F7C-B7D4373E83C8Q33680230-448B442A-365D-40F8-A4D5-CE0B260BD841Q33852775-ED7C61A0-D6B7-4EEC-9C9C-20D24A7A4805Q33918694-DC45072E-5F7C-4ABD-96ED-53AD9950EECAQ34182483-B8E60903-1A07-466E-B1C4-71A4ED9FDE56Q34659512-C7833896-5D32-4604-99F9-A48A8CFBE1B0Q34785138-37FC2B90-3FC1-410A-9948-2C1071754605Q35022507-675619A3-3B1F-4199-940D-4D7E56A5DE02Q35748803-2932BC2E-9985-4348-8494-FA7388CE9AB5Q36431650-9A13B3E8-B687-4F19-AEC9-6D63FB03DC0AQ36431770-F0887F52-8A77-49D9-8B07-ED8EE5371765Q36586442-5048E83B-C56B-4BED-82C4-5E3C27B0C8F4Q36617917-1FBAA2CA-F487-4D91-B3A5-C6D8077D7EC2Q36623673-AFCC5514-2226-47E6-90F6-E0E5FA70DF51Q37011271-5A0016DD-DF04-44BD-A7F2-9BB7EC4FA9CFQ37066021-97856FA3-DE08-4DB1-A988-946D7FF626D2Q37113552-7B02D45C-D83A-450B-BA8C-2EA5C5305F56Q37220672-BB4C5D52-603D-40C7-A623-701D15CCBED8Q37327775-FACC1D5D-9C94-488B-BC8E-2C8B61C199F8Q37353958-867B139B-F16A-44FF-8C26-DCA3EF5CFA7FQ37515263-31D06F9E-59F3-465C-A9EB-89D9085F326CQ37702186-26991ABB-4286-4438-970B-DA58AD9D626AQ38151670-B1F70AB1-512A-48CD-AB31-4B895F9F6C3EQ38321093-823F6C95-B0D4-4AA3-8534-9B57CA2CA805Q39361431-72AECC64-2186-4818-9B51-F8FEC9B5E5B7Q43148137-FAAAFF2A-1530-48D5-BE94-DC584B57375FQ55181109-49FB6508-C8C4-49E3-A009-BBF3DF8C1C7C
P2860
Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@ast
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@en
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@en-gb
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@nl
type
label
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@ast
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@en
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@en-gb
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@nl
prefLabel
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@ast
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@en
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@en-gb
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@nl
P2093
P921
P1433
P1476
Frequent loss of heterozygosit ...... in human hepatocellular tumors
@en
P2093
A T De Souza
G R Hankins
M K Washington
R L Jirtle
P304
P407
P577
1995-05-04T00:00:00Z